Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 07, 2018 17:04 ET | Source: Akorn, Inc.

Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway

LAKE FOREST, Ill., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX) today said it will move forward and rebuild shareholder value as an independent company following the disappointing...
November 26, 2018 17:29 ET | Source: Akorn, Inc.

Akorn Receives Product Approval

LAKE FOREST, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application...
November 06, 2018 17:10 ET | Source: Akorn, Inc.

Akorn Provides Third Quarter 2018 Results

LAKE FOREST, Ill., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the third quarter of...
October 29, 2018 07:05 ET | Source: Akorn, Inc.

Akorn Receives Product Approval

LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new...
October 18, 2018 13:47 ET | Source: Akorn, Inc.

Akorn Appeals Fresenius Kabi Ruling

LAKE FOREST, Ill., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that the company filed a notice of appeal to the...
October 10, 2018 07:05 ET | Source: Akorn, Inc.

Akorn Receives Product Approval

LAKE FOREST, Ill., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it has received a new Abbreviated New Drug...
February 26, 2018 19:47 ET | Source: Akorn, Inc.

Akorn Issues Statement on Investigation

LAKE FOREST, Ill., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today issued the following statement: “Akorn and Fresenius Kabi...
July 19, 2017 16:30 ET | Source: Akorn, Inc.

Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi

LAKE FOREST, Ill., July 19, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, announced that its shareholders, at a special meeting held earlier...
April 07, 2017 17:58 ET | Source: Akorn, Inc.

Akorn Confirms Discussions with Fresenius Kabi

LAKE FOREST, Ill., April 07, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today confirmed that Akorn is currently in discussions with...
March 02, 2017 08:24 ET | Source: Akorn, Inc.

Akorn Receives FDA Approval for Ephedrine Sulfate Injection, USP

LAKE FOREST, Ill., March 02, 2017 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generics pharmaceutical company, today announced that it has received approval from the U.S. Food...